BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Hydromer, Inc. (HYDI) Enters Into Medical Coating Licenses With Two International Medical Device Companies


2/26/2013 9:46:16 AM

BRANCHBURG, NJ--(Marketwire - February 25, 2013) -

Hydromer, Inc. (OTC Pink: HYDI) announced that during the last 30 days it entered into License Agreements with two non-USA based medical device manufacturers.

In January 2013, an Agreement was entered with a Chinese Medical Device company licensing the use of a proprietary Hydromer® medical coating for use on Nelaton Urinary Self-Catheters. The Chinese Medical Device company intends to manufacture the catheters in China and sell the coated product globally.

In early February 2013, an Agreement was entered with a United Arab Emirates based Medical Device company licensing the use of two proprietary Hydromer® medical coatings for use on PTCA/PTA Catheters. This UAE based Medical Device company intends to market their precision vascular access catheters in the Middle East and Global markets.

"Our focus in the lucrative and rapidly growing Chinese Medical Device market is gaining momentum as more Chinese companies are evaluating our coatings which have previous approvals with international regulatory agencies such as the US FDA, SFDA, CE/ISO, Japanese and others," commented Martin von Dyck, Executive Vice President of Hydromer, Inc., adding, "We are quite proud with our new UAE relationship, who selected Hydromer coatings based on our superior performance, previous regulatory approvals and high certainty of preventing particulate contamination in the blood stream. Hydromer coatings continually pass the USP 788 Particulate Matter in Injections test and the challenging Japanese Ministry of Health's Eluate test as well as the stringent ISO 8536-4 and China's GB/T14233.1 tests for reducing oxidizable matter. Passing all of these required tests ensures that Hydromer medical coatings continue to be prized globally as a premium biocompatible value added product."

About Hydromer, Inc.: Hydromer, Inc. is a bio-technology-based company involved in the research and development, manufacture, contract coating and commercialization of specialized polymer and hydrogel products for medical device, animal health, cosmetic, personal care, and industrial uses. These technologies include Hydromer lubricious / anti-microbial / anti-thrombogenic / cell anti-mitosis / cell growth enhancing coatings for the medical marketplace.

For additional information please visit the following Web-sites:
www.hydromer.com

Hydromer ® is a registered trademark of Hydromer, Inc.


Contact:
Martin von Dyck
Executive Vice President

35 Industrial Parkway
Branchburg, NJ. USA
Phone 908 722 5000
www.hydromer.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->